External Source

Impower150 Data For Immunotherapy Quadruplet In Egfr-mutant Lung Cancer

2019 1:41
Synopsis
Edward B. Garon, MD, director of thoracic oncology at the David Geffen School of Medicine at UCLA, discusses data from the ...

You Might Also Like

The IMpower150 Regimen 5:08
The Impower150 Regimen
2020
IMpower-150: EGFR-Mutated Subset Analysis 5:55
Impower-150: Egfr-mutated Subset Analysis
2018
Quadruplet Therapy in NSCLC: IMpower150 8:08
Quadruplet Therapy In Nsclc: Impower150
2018
IMpower150: Quadruplet Therapy for Nonsquamous mNSCLC 4:49
Impower150: Quadruplet Therapy For Nonsquamous Mnsclc
2018
IMpower150: Combining VEGF and I-O Therapy in NSCLC 5:47
Impower150: Combining Vegf And I-o Therapy In Nsclc
2018
Emerging Data in EGFR-Mutant Lung Cancer 7:08
Emerging Data In Egfr-mutant Lung Cancer
2017
IMpower150: efficacy outcomes of atezolizumab addition in pre-treated EGFR-mutated NSCLC 1:31
Impower150: Efficacy Outcomes Of Atezolizumab Addition In Pr...
2019
Dr. Kim Discusses Data From the IMpower150 Trial in Nonsquamous NSCLC 2:11
Dr. Kim Discusses Data From The Impower150 Trial In Nonsquam...
2019
Dr. Bertino on the Impact of the EGFR-Mutated Subset Analysis of IMpower150 in NSCLC 1:29
Dr. Bertino On The Impact Of The Egfr-mutated Subset Analysi...
2020
Looking at the IMpower Data in NSCLC 3:18
Looking At The Impower Data In Nsclc
2019
Real-world experience of Impower150 regimen for EGFR+ NSCLC 1:33
Real-world Experience Of Impower150 Regimen For Egfr+ Nsclc
2020
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.